Acute Myeloid Leukemia Secondary to Treatment with Oxaliplatin Combined with Capecitabine for Colorectal Cancer
CONCLUSIONS: We suggest that clinicians conduct long-term epidemiological follow-up and epidemiological investigations on patients treated with oxaliplatin and capecitabine. In addition, clinicians should carefully check the complete blood cell count on routine follow-ups and observe the morphological changes of white blood cells in peripheral blood smears, even for asymptomatic patients who have undergone chemotherapy. In this way, we can observe the possibility of its development into secondary leukemia.PMID:38469787 | DOI:10.7754/Clin.Lab.2023.230946
Source: Clinical Colorectal Cancer - Category: Cancer & Oncology Authors: Juan Xie Meiqing Li Peizhang Li Ying Wang Naiqi Pang Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Anemia | Bone Marrow Aspiration and Biopsy | Cancer | Cancer & Oncology | Chemotherapy | Colorectal Cancer | Eloxatin | Epidemiology | Leukemia | Papanicolaou (Pap) Smear | Study | Thrombocytopenia | Xeloda